Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jasper Therapeutics, Inc. - Class A Common Stock (NQ:JSPR)

3.340 -0.130 (-3.74%)
Streaming Delayed Price Updated: 3:09 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Jasper Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
Jasper Therapeutics Gets Hit With Downgrades Over Faulty Batch Of Skin Allergy Drug; Retail Sees ‘Overreaction’
The company flagged that 10 of 13 patients in two dosing cohorts received a compromised batch of briquilimab, leading to muted results. 
Via Stocktwits
Top stock movements in today's session.
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem
Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and halted pipeline programs. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips 
Via InvestorPlace
Jasper Therapeutics: Q3 Earnings Insights
Via Benzinga
Dow Dips 1%; Mustang Bio Shares Spike Higher
Via Benzinga
Topics Stocks
Here are the top movers in Monday's session.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS
Via Benzinga
What's going on in today's pre-market session
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Russell 2000 Index Forecast As The Crash Continues: Buy The Dip?
The Russell 2000 Index has plunged and formed a death cross this year as American stocks sink amid rising worries about Donald Trump’s policies. 
Via Talk Markets
Topics Government Stocks / Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Crude Oil Down 1%; US Weekly Jobless Claims Decline
Via Benzinga
Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors
Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025. 
Via Benzinga
US Stocks Down; Acuity Brands Posts Weak Revenue
Via Benzinga
Futures Slump As Yields, Dollar Soar
In premarket trading Quantum stocks tumbled after Nvidia CEO Jensen Huang said that “very useful” quantum computers are likely decades away. 
Via Talk Markets
Topics Commodities Stocks / Equities
Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday?
Jasper Therapeutics' SPOTLIGHT study reports 93% clinical response in cold urticaria and symptomatic dermographism. The 120mg dose showed 83% complete response and no severe adverse events. Full data... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024
JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q1 2024
JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.